Gilmore Neil O'Neill

CEO, Director, Editas Medicine, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Sep 3, 2026

Companies

Editas Medicine, Inc.CEO, Director −$0.1M

Trades

EDIT Sold 5,124 shares at $3.04 · planned $0.0M Sep 3

EDIT Sold 15,380 shares at $2.70 · planned $0.0M Jun 3

EDIT Sold 5,394 shares at $2.02 · planned $0.0M Mar 3

EDIT Sold 5,603 shares at $2.15 · planned $0.0M Dec 3

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.